MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Preference and satisfaction of the Deep Brain Stimulation Battery in Patients with Parkinson’s Disease

X. Qiu, CC. Zhang, Z.Y Lin, D.Y Li (Shanghai, China)

Meeting: MDS Virtual Congress 2020

Abstract Number: 1364

Keywords: Deep brain stimulation (DBS)

Category: Surgical Therapy: Parkinson's Disease

Objective: To evaluate the preference and satisfaction of the deep brain stimulation implantable pulse generator in patients with Parkinson’s disease.

Background: Deep brain stimulation (DBS) is an established treatment for movement disorder. Implantable pulse generators (implantable pulse generators/batteries) for DBS were now a choice between fixed-life and rechargeable batteries, with each having their advantages and disadvantages.

Method: Two hundred and twenty patients with DBS were given a self-designed questionnaire to assess long-term satisfaction and experience with the type of battery they had chosen, and the influenced factors of implanted pulse generator choose. The survey was performed online (WeChat) and double-checked for completeness and accuracy.

Results: The mean follow-up was 27.5 ± 32.4 months. The most popular way for patients to appreciate DBS surgery was media (79/220, 35.9%), including the Internet and television programs. Interestingly, the remote programming feature significantly affected patients’ choice between products of domestic and imported brands (χ2 = 16.81, p = 0.00). 87.7% patients satisfied with stimulating effects as well as the implanted device. 87.3% DBS were rechargeable device (r-IPG). The choice between rechargeable and non-rechargeable IPG was significantly associated with the patient’s affordability (χ2 = 19.13, p = 0.00). 40.6% patients with r-IPG felt confident with their device within one week after discharge. More than half of the patients checked battery every week. The mean interval for battery recharge was 4.3 days. 57.8% patients spending around one-hour recharging and 71.4% of them recharge the battery independently. The rehabilitation (40.6%, 78/192), as well as programming (36.5%, 70/192), were two main courses that patients mostly wanted to learn during follow-up.

Conclusion: Most patients are satisfied with their choice of IPG.  The patients’ economic status and remote programming feature seem like the most critical factors in their decision. The skill of using rechargeable implanted pulse generator was easily to be capable by most patients. Rehabilitation and self-programming skill are demanded in patients.

To cite this abstract in AMA style:

X. Qiu, CC. Zhang, Z.Y Lin, D.Y Li. Preference and satisfaction of the Deep Brain Stimulation Battery in Patients with Parkinson’s Disease [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/preference-and-satisfaction-of-the-deep-brain-stimulation-battery-in-patients-with-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/preference-and-satisfaction-of-the-deep-brain-stimulation-battery-in-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley